VitaNova Life Sciences (VNOV) Other Non Operating Income (2021 - 2026)

VitaNova Life Sciences has disclosed Other Non Operating Income across 4 years of filings, most recently posting $673.0 for Q3 2026.

• Other Non Operating Income for Q3 2026 came in at $673.0, down 96.13% year-over-year; the trailing twelve-month figure through Jul 2026 was -$2478.0 (down 113.86% YoY), and the FY2026 annual result was -$3151.0, down 735.28% from the prior year.
• Other Non Operating Income for Q3 2026 stood at $673.0, up from -$3271.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $17388.0 in Q3 2025 and bottomed at -$3271.0 in Q2 2026.
• Average Other Non Operating Income over 3 years is $2215.9, with a median of $196.0 recorded in 2025.
• The widest annual swing landed in 2025, when Other Non Operating Income tumbled 60.0%; it then plunged 96.13% in 2026.
• Year by year, Other Non Operating Income stood at $300.0 in 2024, then slumped by 60.0% to $120.0 in 2025, then surged by 460.83% to $673.0 in 2026.
• The last three Other Non Operating Income figures came in at $673.0 (Q3 2026), -$3271.0 (Q2 2026), and $120.0 (Q4 2025), per Business Quant data.